| 参考文献 |
|---|
Wu T, Rabi S, Michaud W, Becerra D, Gilpin S, Mino Kenudson M, et al. Protease inhibitor Camostat Mesyalte blocks wild type SARS-CoV-2 and D614G viral entry in human engineered miniature lungs. Biomaterials. 2022;285:121509 pubmed 出版商 |
Funari R, Fukuyama H, Shen A. Nanoplasmonic multiplex biosensing for COVID-19 vaccines. Biosens Bioelectron. 2022;208:114193 pubmed 出版商 |
Yang Z, Han Y, Ding S, Shi W, Zhou T, Finzi A, et al. SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy. MBio. 2022;:e0322721 pubmed 出版商 |
Chiuppesi F, Nguyen V, Park Y, Contreras H, Karpinski V, Faircloth K, et al. Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates. NPJ Vaccines. 2022;7:7 pubmed 出版商 |
Peralta Garcia A, Torrens Fontanals M, Stępniewski T, Grau Expósito J, Perea D, Ayinampudi V, et al. Entrectinib-A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells. Int J Mol Sci. 2021;22: pubmed 出版商 |
Lassauniere R, Polacek C, Gram G, Frische A, Tingstedt J, Krüger M, et al. Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2. NPJ Vaccines. 2021;6:156 pubmed 出版商 |
Li J, Xu D, Wang L, Zhang M, Zhang G, Li E, et al. Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment. Molecules. 2021;26: pubmed 出版商 |
Muecksch F, Weisblum Y, Barnes C, Schmidt F, Schaefer Babajew D, Wang Z, et al. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity. 2021;54:1853-1868.e7 pubmed 出版商 |
Postnikova O, Uppal S, Huang W, KANE M, Villasmil R, Rogozin I, et al. The Functional Consequences of the Novel Ribosomal Pausing Site in SARS-CoV-2 Spike Glycoprotein RNA. Int J Mol Sci. 2021;22: pubmed 出版商 |
Chen Y, Lear T, EVANKOVICH J, Larsen M, Lin B, Alfaras I, et al. A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry. Nat Commun. 2021;12:3907 pubmed 出版商 |
Kim Y, Lee M, Lee S, Chung H, Kim K, Lee T, et al. Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library. Int J Mol Sci. 2021;22: pubmed 出版商 |
Ozono S, Zhang Y, Ode H, Sano K, Tan T, Imai K, et al. SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity. Nat Commun. 2021;12:848 pubmed 出版商 |
Chiuppesi F, Salazar M, Contreras H, Nguyen V, Martinez J, Park Y, et al. Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform. Nat Commun. 2020;11:6121 pubmed 出版商 |
Lu M, Uchil P, Li W, Zheng D, Terry D, Gorman J, et al. Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles. Cell Host Microbe. 2020;28:880-891.e8 pubmed 出版商 |
Wang S, Peng Y, Wang R, Jiao S, Wang M, Huang W, et al. Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys. Nat Commun. 2020;11:5752 pubmed 出版商 |
Yi C, Sun X, Ye J, Ding L, Liu M, Yang Z, et al. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Cell Mol Immunol. 2020;17:621-630 pubmed 出版商 |
